𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of Angiogenesis-Relevant Receptor Tyrosine Kinases by Sulindac Analogues

✍ Scribed by Eleni Gourzoulidou; Mercedes Carpintero; Patrick Baumhof; Athanassios Giannis; Herbert Waldmann

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
129 KB
Volume
6
Category
Article
ISSN
1439-4227

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Inhibition of peritoneal dissemination o
Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68)
✍ Shizuo Machida; Yasushi Saga; Yuji Takei; Izumi Mizuno; Takeshi Takayama; Takahi πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 French βš– 230 KB πŸ‘ 1 views

## Abstract SU6668 (TSU‐68) is a small‐molecule synthetic inhibitor of the angiogenic related receptor tyrosine kinases Flk‐1/KDR, PDGFRΞ², and FGFR1. Using a mouse model of peritoneally disseminated ovarian cancer, we investigated whether SU6668 inhibits peritoneal dissemination and prolongs surviv

Targeted inhibition of the epidermal gro
Targeted inhibition of the epidermal growth factor receptor-tyrosine kinase by ZD1839 (β€˜Iressa’) induces cell-cycle arrest and inhibits proliferation in prostate cancer cells
✍ Alessandro Sgambato; Andrea Camerini; Beatrice Faraglia; Raffaele Ardito; Gabrie πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 297 KB

## Abstract The epidermal growth factor (EGF) plays a role in the development of prostate cancer, which becomes essential after androgen resistance has emerged. The EGF receptor (EGFR) is therefore a potential target for anticancer therapy. We evaluated the effects of ZD1839 (β€˜Iressa’), an orally a